Evidence map›Paper›PMID 41346732›Full record

ReviewFrontiers in surgery2025

Tranexamic acid in arthroscopic surgery: efficacy, safety, and clinical considerations.

Wei Wang, Qi Ru Tian, Sheng Li

Abstract readReview
In one paragraph

Review in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wei Wang *Hainan Vocational University of Science and Technology, Haikou, Hainan, China.
Qi Ru Tian *Hainan Vocational University of Science and Technology, Haikou, Hainan, China.
Sheng LiCentral Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study reviews the applications and effects of tranexamic acid in arthroscopic surgery. Bleeding during arthroscopic surgery is an important factor affecting surgical outcomes and postoperative recovery. Tranexamic acid is an anti fibrinolytic drug that can effectively inhibit fibrin degradation and may be helpful in reducing surgical bleeding and improving surgical field clarity. In this review, the pharmacological mechanism of tranexamic acid is first introduced, including its effect on the fibrinolytic system and its specific mechanism of action to reduce bleeding. Subsequently, the review describes the application of tranexamic acid in arthroscopic surgery, analyzes the safety of tranexamic acid in arthroscopic surgery, and related factors affecting the effectiveness of tranexamic in arthroscopic surgery. In addition, this review highlights future research directions regarding tranexamic acid in arthroscopic surgery. A comprehensive analysis of existing literature indicates that tranexamic acid has an impact on blood loss, pain, surgical time, surgical field clarity, and postoperative function during arthroscopic surgery. Therefore, the application of tranexamic acid in arthroscopic surgery has high clinical value and significance.

Indexed as

applicationarthroscopic surgeryblood losssafetytranexamic acid

Identifiers

PMID41346732
PMCPMC12672481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.